Kali-Extracts To Franchise Its Patented Cannabis Extraction Service Nationwide After President Trump Legalizes Hemp Farming
December 21 2018 - 9:11AM
InvestorsHub NewsWire
DALLAS, TX - Dec
21, 2018 -- InvestorsHub NewsWire -
Kali, Inc. (dba/Kali-Extracts,
Inc.) (USOTC:
KALY) (“KALY”) today announced plans to launch a hemp-derived
CBD extraction franchise business following President Trump signing
the Farm Bill legalizing hemp farming into law. KALY owns and
operates a patented cannabis extraction process - U.S. Patent No.
9,199,960 entitled 'METHOD AND APPARATUS FOR PROCESSING HERBACEOUS
PLANT MATERIALS INCLUDING THE CANNABIS PLANT'. The company
has conducted numerous preclinical trials for a variety of
disease therapies based on cannabis extracts derived from its
cannabis process. The company also has experience producing
commercial extractions for infusion into nutrition and wellness
products. “I don’t think any cannabis extractor has more
credibility or experience than we do with our patented process and
preclinical trial results,” said Frederick Ferri, CEO of
Kali-Extracts. “Hemp farmers will need CBD extraction services and
can’t afford to risk their crop with an inexperienced or first-time
extractor. Our franchise process will deploy trained
extractors with a patented and proven process nationwide.”
Kali-Extracts plans to begin marketing the CBD extraction franchise
in February.
KALY produces pharmaceutical grade
cannabis extracts that have been involved in multiple clinical
trials in addition to utilizing its patented cannabis extraction
process in the production of CBD infused nutrition and wellness
products to include its own Hemp4mula and CBD infused waters
produced by Puration, Inc. (USOTC:
PURA) (“PURA”).
KALY is partners with PURA and Nouveau
Life Pharmaceuticals (USOTC:
NOUV) in a joint venture named US Cannabis Health for the
purpose of together developing partnerships with pharmaceutical
companies to develop cannabis pharmaceuticals. US Cannabis
Health recently announced its first agreement with Generex
Biotechnology, Corp. (OTCQB:
GNBT).
To learn more about the KALY and NOUV
project announced today, follow developments online at www.kali-extracts.com.
Disclaimer/Safe
Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any
disease.
Kali,
Inc.
Frederick Ferri
ir@kali-extracts.com
(214)
210-0459
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Apr 2023 to Apr 2024